* PepGen Inc PEPG.OQ reported a quarterly adjusted loss
of 66
cents per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -98 cents. The mean expectation of five analysts for the
quarter was for a loss of 87 cents per share. Wall Street
expected results to range from -98 cents to -64 cents per share.
* Reported revenue was zero; analysts expected zero.
* PepGen Inc's reported EPS for the quarter was a loss of 66
cents.
* The company reported a quarterly loss of $21.38 million.
* PepGen Inc shares had fallen by 34.2% this quarter and
lost 17.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 4.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for PepGen Inc is
17.00
This summary was machine generated from LSEG data November 8 at
04:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.87 -0.66 Beat
Jun. 30 2024 -0.72 -0.87 Missed
Mar. 31 2024 -0.74 -0.63 Beat
Dec. 31 2023 -1.01 -0.81 Beat